Wednesday, April 7, 2010 as of 11:14 AM ET
The pharmaceutical industry develops, produces, and markets drugs licensed for use as medications. Pharmaceutical companies are allowed to deal in generic and/or brand medications and medical devices.
Read More at Wikipedia ›Global drug companies are working with European authorities on how to keep medicines flowing into Greece if the country is forced out of the region's single currency and can't pay for such products.
"There is no concrete plan but there is an understanding that, if something happened, we would need to move swiftly and the industry is prepared to take a reasonable approach," said Richard Bergstrom, director general of the European Federation of Pharmaceutical Industries and Associations."There are historic precedents where the pharmaceuticals industry has behaved very rationally and responsibly together with governments," Bergstrom said, citing as an example Argentina's collapse in 2002, when some drug manufacturers continued supplying medicines without payment for a period of time."There will be a discussion of an orderly arrangement, but this topic is totally forbidden to be discussed in the EU Commission and that's why there are no overall plans. But it is first and foremost the compan...Sanofi CEO Chris Viehbacher gives his outlook for economic growth.
The sudden willingness of European drug companies to launch hostile takeover bids -- underscored by numerous bids this month -- underlines the depth of the sector's ...
Deutsche Bank AG (DB, DBK.XE) said Wednesday it will book a EUR257 million impairment charge in the first quarter from exiting its exposure to generic drug maker Act...
("UPDATE: Shanghai Fosun Pharmaceutical Gets HK Regulator's OK For HK IPO - Source," at 0721 GMT, misstated that Shanghai Fosun's parent is unlisted in the first par...
The Leuthold Group founder Steve Leuthold on the outlook for Apple and the markets as a whole.
DOW JONES NEWSWIRESHuman Genome Sciences Inc. (HGSI) received an unsolicited takeover bid worth $2.58 billion in cash from GlaxoSmithKline PLC (GSK), an offer the bi...
(This story has been posted on The Wall Street Journal Online's Health Blog at http://blogs.wsj.com/health.)Here's what's making health news this morning:Nestle Is N...
The U.S. Supreme Court handed a victory to generic drug companies Tuesday, ruling they can file certain legal counterclaims against brand-drug companies in an effort...
The U.S. Supreme Court ruled Tuesday that generic drug companies can file certain legal counterclaims against brand-drug companies in an effort to get their cheaper ...
Attorney Mark Lanier on the upcoming case against the pharmaceutical giant.
Schwartz Investment Counsel CEO George Schwartz on the criteria used to choose stocks for the Ave Maria Mutual Funds.
S&P Chief Investment Strategist Sam Stovall and Wells Fargo Chief Economist John Silvia on the outlook for the markets and economy and the impact of Spain on the U.S. economy.
FBN's Tracy Byrnes breaks down afternoon market news.
Major drug makers are reportedly working with European authorities on an emergency plan that would keep medicines flowing to Greece if the embattled country exits th...
FOX News contributor Sally Kohn discusses whether actions from the presidential hopeful’s high school days should impact the election.
Puerto Rico Governor Luis Fortuno discusses how the territory revived its economy.
Here's what's making health news this morning:Goodbye, Lipitor. Pfizer Bids a Farewell (WSJ): After an $87 million marketing push since November, Pfizer is giving up...
The Senate Finance Committee is looking into possible links between three drug companies and nonprofit medical groups, citing concerns about the groups' advocacy of ...
Abbott Laboratories (ABT) agreed to pay $1.6 billion and plead guilty to violating a federal drug law to resolve allegations that the company improperly promoted ant...
